loader

World Tenders & Procurement Opportunities

Search
Advanced Search

859805-Awarded - Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0671 - LETERMOVIR [240 MG CÁP/COMP]

World Biggest Tenders Source

This tender with title 859805-Awarded - Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0671 - LETERMOVIR [240 MG CÁP/COMP] has been published on Bidding Source portal dated 25 Dec 2025 for the country of Portugal. It has been categorized on General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents. For similar tenders you can see tenders mentioned below of this page.

General Information

Portugal

859805-Awarded - Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0671 - LETERMOVIR [240 MG CÁP/COMP]
Contract Award
859805
Portugal
25 Dec 2025
English
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

858116-Awarded - Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0671 - LETERMOVIR [240 MG CÁP/COMP] Portugal 836480-Awarded - Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2024/0900 - LAMIVUDINA + DOLUTEGRAVIR [300 MG + 50 MG COMP] Portugal 692898-Awarded - Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2025/1303- ENTECAVIR [0.5 MG CÁP/COMP] Portugal 692988-Awarded - Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2025/1303- ENTECAVIR [0.5 MG CÁP/COMP]-I Portugal 693638-Awarded - Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2025/1303- ENTECAVIR [0.5 MG CÁP/COMP] Portugal 672511-Awarded - Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0494 - SOFOSBUVIR + VELPATASVIR [400 + 100 MG; TRATAMENTO 12-24 SEMANAS] Portugal 672981-Awarded - Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2024/0900 - EMTRICITABINA + TENOFOVIR ALAFENAMIDA [200 + 25 MG COMP] Portugal 673843-Awarded - Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0491-GLECAPREVIR+PIBRENTASVIR [100 MG+40 MG;TRATAMENTO 8-16 SEMANAS] Portugal 673938-Awarded - Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0494-GLECAPREVIR+PIBRENTASVIR [100 MG+40 MG;TRATAMENTO 8-16 SEMANAS] Portugal 674162-Awarded - Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2023/0494 - SOFOSBUVIR + VELPATASVIR [400 + 100 MG; TRATAMENTO 12-24 SEMANAS] Portugal
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents Tenders
Portugal Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans